Dan Fries

Dan Fries is an entrepreneur and writer. He is the co-author of three highly-cited papers in the field of translational oncology research. Dan’s diverse background includes positions as a research associate at OSI Pharmaceuticals, an associate scientist at Medtronic Cardiovascular, and research scientist at both the Michigan Center for Translational Pathology and the Meyerson Lab at Dana Farber of Harvard Medical School. He currently writes about the responsible use of nutrition and supplementation as a means for treatment. To learn more about Dan and his current research you can visit his website, Corpina Nootropics.